Cherqaoui Driss - Profil du chercheur

Informations du chercheur

Nom complet

Cherqaoui Driss

Grade

PES

Spécialité

Chimie organique

Thématique de recherche

Synthèse organique et modélisation moléculaire

Laboratoire

Laboratoire de Chimie Moléculaire

Établissement

Faculté des Sciences Semlalia Marrakech

Ouvrages (0 au total)

Aucun ouvrage disponible.

Projets (1 au total)

Modélisation moléculaire : Contribution à la conception d’inhibiteurs du VIH

Type: Non spécifié

Début: 01/01/2017

Fin: 30/12/2018

Organisme financeur:

Agence Universitaire de la Francophonie” and the Scientific Research Fund of Bulgaria. under project DNTS/FrPh01/1.

Publications (29 au total)

Deciphering the cytotoxic and antioxidant potential of 3,5-disubstituted isoxazole-linked benzimidazolone derivatives

Auteur: Mohamed Adardour, Soufiane Drioua, Marouane Ait Lahcen, Ismail Hdoufane, Elena Zaballos-García, Mohammed M. Alanazi, Anass Doukkali, Karim Chkirate, Driss Cherqaoui, Joel T. Mague, Abdesselam Baouid

Revue: Journal of Molecular Structure

Année: 2025

DOI: 10.1016/j.molstruc.2024.139683

New Schiff bases and their vanadium complexes: Synthesis, characterization, and biological assessment for antibacterial and antiviral action

Auteur: Khadija Khaldoune, Ali Hasnaoui, Meryem Rafya, Meriem Es‐sakhi, Fatiha Benkhalti, Ismail Hdoufane, Joel T. Mague, Johan Neyts, Dirk Jochmans, Driss Cherqaoui, Larbi el Firdoussi, Naima Fdil, Hassan Bihi Lazrek, Mustapha Ait Ali

Revue: Applied Organometallic Chemistry

Année: 2024

DOI: 10.1002/aoc.7534

Drug design of new anti-EBOV inhibitors: QSAR, homology modeling, molecular docking and molecular dynamics studies

Auteur: Nouhaila Ait Lahcen, Wissal Liman, Mehdi Oubahmane, Ismail Hdoufane, Youssef Habibi, Ashwag S. Alanazi, Mohammed M. Alanazi, Christelle Delaite, Mohamed Maatallah, Driss Cherqaoui

Revue: Arabian Journal of Chemistry

Année: 2024

DOI: 10.1016/j.arabjc.2024.105870

Syntheses, characterization and DFT studies of two new (π-allyl) palladium(II) complexes of β-8,9-dihydrohimachalene

Auteur: Abdelmajid Faris, Youssef Edder, Ismail Hdoufane, Intissar Ait Lahcen, Mohamed Saadi, Lahcen EL Ammari, Moha Berraho, Driss Cherqaoui, Brahim Boualy, Abdallah Karim

Revue: Journal of Coordination Chemistry

Année: 2023

DOI: 10.1080/00958972.2023.2194013

Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations

Auteur: Mehdi Oubahmane, Ismail Hdoufane, Christelle Delaite, Adlane Sayede, Driss Cherqaoui, Achraf El Allali

Revue: Pharmaceuticals

Année: 2023

DOI: 10.3390/ph16040608

Synthesis, characterization, X-ray, α-glucosidase inhibition and molecular docking study of new triazolic systems based on 1,5-benzodiazepine <i>via</i> 1,3-dipolar cycloaddition reactions

Auteur: Marouane Ait Lahcen, Mohamed Adardour, Salma Mortada, Mehdi Oubahmane, Samir Hmaimou, Mohamed Loughzail, Ismail Hdoufane, Sanae Lahmidi, My El Abbes Faouzi, Driss Cherqaoui, Joel T. Mague, Abdesselam Baouid

Revue: Journal of Biomolecular Structure and Dynamics

Année: 2023

DOI: 10.1080/07391102.2023.2203263

Exploring anticancer activity, acute toxicity, and molecular docking of synthesized schiff bases and schiff base-palladium complex

Auteur: Khadija Khaldoune, Ali Hasnaoui, Naima Fdil, Ali Oubella, Karima Lafhal, Mehdi Oubahmane, Ismail Hdoufane, Lahcen El Ammari, Mohamed Saadi, Moha Berraho, My Youssef Ait Itto, Larbi El Firdoussi, Mustapha Ait Ali

Revue: Inorganic Chemistry Communications

Année: 2023

DOI: 10.1016/j.inoche.2023.111089

Crystal Structure, DFT Calculation, and Hirshfeld Surface Analysis of the 1-(Cyclohex-1-en-1-yl)-3-(prop-2-yn-1-yl)-1,3-dihydro-2H-benzimidazol-2-one

Auteur: Mohamed Adardour, Marouane Ait Lahcen, Ismail Hdoufane, Mohammed M. Alanazi, Mohamed Loughzail, Hénia Mousser, Solenne Fleutot, Michel François, Driss Cherqaoui, Abdesselam Baouid

Revue: Crystals

Année: 2023

DOI: 10.3390/cryst13121661

Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel Pyrazole Benzimidazolone Derivatives as Potent Antioxidants

Auteur: Mohamed Adardour, Marouane Ait Lahcen, Mehdi Oubahmane, Walid Ettahiri, Ismail Hdoufane, Hafida Bouamama, Mohammed M. Alanazi, Driss Cherqaoui, Mustapha Taleb, Elena Zaballos Garcia, Abdesselam Baouid

Revue: Pharmaceuticals

Année: 2023

DOI: 10.3390/ph16121648

1 2 3 Suivant »

Communications (22 au total)

Combined singular value decomposition and linear regression methods in QSAR modelling: a case study for predicting HIV-1 and HCV biological activities

Manifestation: International Congress of &bdquo;Apollonia” University from Iași By promoting excellence, we prepare the future Edition XXXI

Date: 2021-03-01

Organisation: IAȘI, ROMANIA

Impact assessment of singular value decomposition linear regression model on QSAR modelling: A case study for predicting HIV-1 and HCV biological activities.

Manifestation: Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2019)

Date: 2019-06-23

Organisation: Ioannina, Greece.

Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase through Target-Focused Modelling

Manifestation: 2nd MMCS - Facing Novel Challenges in Drug Discovery

Date: 2019-05-15

Organisation: Barcelona, Spain

Molecular modeling: Application of Artificial Neural Networks, Support Vector Machines and Decision Trees for anti HIV activity prediction of organic compounds

Manifestation: 5th International Conference on Computation for Science and Technology (ICCST 2018)

Date: 2018-09-23

Organisation: Antalya Turkey

QSAR models for assessment of the potential of azaindole analogs as HIV-1 attachment inhibitors

Manifestation: 25th Congress of the Society of Chemists and Technologists of Macedonia (SCTM)

Date: 2018-09-19

Organisation: Ohrid Macedonia

Molecular docking study to understand the binding mechanism of HIV-1 attachment inhibitors

Manifestation: The 3rd Forum of scientific research

Date: 2018-05-11

Organisation: Marrakech, Morocco

Binding energy-based approaches to enhance virtual screening in drug discovery workflows

Manifestation: International Conference on Drug Discovery: Biotechnology and Pharma at Cross Roads

Date: 2018-02-15

Organisation: Patiala-India

SAR Studies for the in-silico Prediction of HIV-1 Inhibitors

Manifestation: 3rd International Electronic Conference on Medicinal Chemistry

Date: 2017-11-01

Organisation: Online

Hydrocarbures et clusters des éléments du groupe 13, Analyse énergétiques et considérations écologiques

Manifestation: International Conference on theoretical chemistry and Modeling

Date: 2017-06-15

Organisation: Kenitra, Morocco. March 15-17, (2017).

« Précédent 1 2 3 Suivant »

Thèses (3 au total)

In Silico Drug Design of Potent SARS-CoV-2 Inhibitors

Auteur: Mehdi OUBAHMANE

Directeur: Cherqaoui Driss

Soutenance: 2023

Molecular Modeling: QSAR Studies on Reverse Transcriptase and Gp120 HIV-1 and NS4B HCV Inhibitors

Auteur: HDOUFANE Ismail

Directeur: Cherqaoui Driss

Soutenance: 2021

Targeting Protein Degradation as a Potential and Emerging Therapeutic Approach in Cancer Drug Discovery: Combinatorial In Silico Modeling to Explore the Covalent & Non-covalent Inhibition of Nedd4-1 E3 Ubiquitin Ligase

Auteur: BJIJ Imane

Directeur: Cherqaoui Driss

Soutenance: 2019

Informations du chercheur

Nom complet

Grade

Spécialité

Thématique de recherche

Laboratoire

Établissement

Ouvrages (0 au total)

Projets (1 au total)

Mod&eacute;lisation mol&eacute;culaire : Contribution &agrave; la conception d&rsquo;inhibiteurs du VIH

Publications (29 au total)

Deciphering the cytotoxic and antioxidant potential of 3,5-disubstituted isoxazole-linked benzimidazolone derivatives

New Schiff bases and their vanadium complexes: Synthesis, characterization, and biological assessment for antibacterial and antiviral action

Drug design of new anti-EBOV inhibitors: QSAR, homology modeling, molecular docking and molecular dynamics studies

Syntheses, characterization and DFT studies of two new (π-allyl) palladium(II) complexes of β-8,9-dihydrohimachalene

Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations

Synthesis, characterization, X-ray, α-glucosidase inhibition and molecular docking study of new triazolic systems based on 1,5-benzodiazepine <i>via</i> 1,3-dipolar cycloaddition reactions

Exploring anticancer activity, acute toxicity, and molecular docking of synthesized schiff bases and schiff base-palladium complex

Crystal Structure, DFT Calculation, and Hirshfeld Surface Analysis of the 1-(Cyclohex-1-en-1-yl)-3-(prop-2-yn-1-yl)-1,3-dihydro-2H-benzimidazol-2-one

Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel Pyrazole Benzimidazolone Derivatives as Potent Antioxidants

Communications (22 au total)

Combined singular value decomposition and linear regression methods in QSAR modelling: a case study for predicting HIV-1 and HCV biological activities

Impact assessment of singular value decomposition linear regression model on QSAR modelling: A case study for predicting HIV-1 and HCV biological activities.

Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase through Target-Focused Modelling

Molecular modeling: Application of Artificial Neural Networks, Support Vector Machines and Decision Trees for anti HIV activity prediction of organic compounds

QSAR models for assessment of the potential of azaindole analogs as HIV-1 attachment inhibitors

Molecular docking study to understand the binding mechanism of HIV-1 attachment inhibitors

Binding energy-based approaches to enhance virtual screening in drug discovery workflows

SAR Studies for the in-silico Prediction of HIV-1 Inhibitors

Hydrocarbures et clusters des &eacute;l&eacute;ments du groupe 13, Analyse &eacute;nerg&eacute;tiques et consid&eacute;rations &eacute;cologiques

Thèses (3 au total)

In Silico Drug Design of Potent SARS-CoV-2 Inhibitors

Molecular Modeling: QSAR Studies on Reverse Transcriptase and Gp120 HIV-1 and NS4B HCV Inhibitors

Targeting Protein Degradation as a Potential and Emerging Therapeutic Approach in Cancer Drug Discovery: Combinatorial In Silico Modeling to Explore the Covalent &amp; Non-covalent Inhibition of Nedd4-1 E3 Ubiquitin Ligase

Modélisation moléculaire : Contribution à la conception d’inhibiteurs du VIH

Hydrocarbures et clusters des éléments du groupe 13, Analyse énergétiques et considérations écologiques

Targeting Protein Degradation as a Potential and Emerging Therapeutic Approach in Cancer Drug Discovery: Combinatorial In Silico Modeling to Explore the Covalent & Non-covalent Inhibition of Nedd4-1 E3 Ubiquitin Ligase